IGF2R Expression is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC
Background: Insulin-like growth factor (IGF) pathway has been suggested as a new molecular target for the treatment of cancer including Non-small cell lung cancer (NSCLC). We postulated that IGF-2 receptor (IGF2R) may be associated with treatment response and prognosis of NSCLC patients receiving ch...
Main Authors: | Zhennan Tian, Guodong Yao, Hongtao Song, Yang Zhou, Jingshu Geng |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2014-10-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/366361 |
Similar Items
-
Notch 3 Protein, not its Gene Polymorphism, is Associated with the Chemotherapy Response and Prognosis of Advanced NSCLC Patients
by: Chunlei Shi, et al.
Published: (2014-08-01) -
Correlations between IGF-IR Expression and Clinicopathological Factors and Prognosis in Patients with Lung Adenocarcinoma
by: Xueyan ZHANG, et al.
Published: (2010-12-01) -
Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
by: Zhao M, et al.
Published: (2020-08-01) -
The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis
by: Jun Zhao, et al.
Published: (2017-09-01) -
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
by: de Groot S, et al.
Published: (2017-06-01)